Miyako Capital: A venture capital firm investing in academia-industry startups to enhance their value.
10
Operating
2013
Kyoto, Kyoto Prefecture, JP
Miyako Capital focuses on investing in industry-academia collaboration startups, particularly those emerging from Kyoto University and other academic institutions. The firm aims to enhance the value of businesses originating from universities and research institutes, bridging the gap between academic innovation and commercial success.
Notable portfolio companies include Viage Therapeutics and VLP Therapeutics, which have raised significant funding. Miyako Capital typically participates in Seed and Series A rounds, demonstrating their commitment to supporting early-stage ventures. The firm's unique position at the intersection of academia and industry allows them to identify and nurture promising technologies with high commercial potential.
Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Portfolio Companies3
Follow-on Investments2
Current Portfolio Count3
Top Investment Stages
Series A2 (40.0%)
Series B2 (40.0%)
Seed1 (20.0%)
Stage Mix
Series A 40%Series B 40%Seed 20%
Concentration shown as share of disclosed investments by stage.
